Drug intelligence / Profile preview

glutathione + ketamine

Development stage
Unknown
Lead developer
Yale University
Modality
Small Molecules, Peptides
Administration
Intravenous
01

Overview

Glutathione + ketamine is a combination therapy involving the administration of both glutathione, a tripeptide antioxidant, and ketamine, an NMDA receptor antagonist. Glutathione acts as a master antioxidant in the body, reducing oxidative stress and inflammation by neutralizing free radicals and supporting cellular detoxification processes. Ketamine is primarily used as an anesthetic and for treatment-resistant depression; it exerts its effects mainly through antagonism of the N-methyl-D-aspartate (NMDA) receptor on neurons, modulating glutamatergic neurotransmission and promoting neuroplasticity. The combination has been explored in clinical settings to determine whether adding intravenous (IV) glutathione to standard ketamine infusion improves outcomes in conditions such as major depressive disorder (MDD). While studies show that both agents are effective individually—ketamine for rapid antidepressant effects and glutathione for reducing oxidative stress—current evidence does not demonstrate significant additional benefit from combining them compared to ketamine alone[2][4]. This combination is typically administered via IV infusion protocols at specialized clinics.

02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on glutathione + ketamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glutathione + ketamine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call